Publication | Closed Access
Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) for resectable esophagogastric cancer: Updated results from multicenter, randomized phase 3 FLOT4-AIO trial (German Gastric Group at AIO)
42
Citations
0
References
2017
Year
Surgical OncologyEsophagusResectable Esophagogastric CancerGastrointestinal OncologyFlot4-aio TrialMedicineGerman Gastric GroupGastroenterologyPathologySurgeryOncologyRadiation OncologyEsophageal SurgeryCancer Research
No additional data available for this publication yet. Check back later!